PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 184 filers reported holding PTC THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,300,987 | -13.5% | 56,577 | +3.0% | 0.52% | -20.2% |
| Q1 2023 | $2,659,647 | -19.6% | 54,906 | -36.7% | 0.64% | -14.8% |
| Q4 2022 | $3,309,034 | -24.0% | 86,692 | 0.0% | 0.76% | -32.5% |
| Q3 2022 | $4,352,000 | +28.0% | 86,692 | +2.2% | 1.12% | +47.4% |
| Q2 2022 | $3,400,000 | +14.1% | 84,864 | +6.3% | 0.76% | +17.4% |
| Q1 2022 | $2,980,000 | -35.0% | 79,864 | -11.7% | 0.65% | -31.6% |
| Q2 2020 | $4,587,000 | +35.3% | 90,396 | +18.9% | 0.95% | +31.0% |
| Q1 2020 | $3,390,000 | -29.6% | 75,996 | -24.2% | 0.72% | -6.2% |
| Q4 2019 | $4,813,000 | +17.2% | 100,202 | -17.5% | 0.77% | +11.1% |
| Q3 2019 | $4,106,000 | -60.2% | 121,402 | -47.1% | 0.69% | -58.2% |
| Q2 2019 | $10,327,000 | +40.9% | 229,498 | +17.8% | 1.66% | +41.2% |
| Q1 2019 | $7,330,000 | – | 194,743 | – | 1.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 7,235,196 | $162,140,742 | 3.42% |
| Camber Capital Management LP | 3,400,000 | $76,194 | 2.51% |
| ARMISTICE CAPITAL, LLC | 6,150,000 | $137,821,500 | 2.11% |
| GREAT POINT PARTNERS LLC | 500,000 | $11,205,000 | 2.04% |
| COWEN AND COMPANY, LLC | 799,511 | $17,917,041 | 1.25% |
| GEORGE KAISER FAMILY FOUNDATION | 45,816 | $6,491,211 | 1.22% |
| SPHERA FUNDS MANAGEMENT LTD. | 218,459 | $4,895,666 | 0.89% |
| SECTORAL ASSET MANAGEMENT INC | 187,016 | $4,191,029 | 0.82% |
| Nebula Research & Development LLC | 21,858 | $489,838 | 0.26% |
| Phocas Financial Corp. | 64,701 | $1,450,000 | 0.21% |